Jack Phillips - 30 Sep 2021 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Reporting relationship: Chief Executive Officer
Issuer ticker: AXDX
Reported as of: 30 Sep 2021
Net transaction value: +$33,331
SEC form: 4
Accepted by SEC: 10 Dec 2021, 14:57:22 UTC
Prior SEC filing: 24 Jun 2021
Next SEC filing: 07 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Steven Reichling, attorney-in-fact

Key filing fact

Jack Phillips filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 10 Dec 2021.

Key facts

This page summarizes Jack Phillips's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Dec 2021, 14:57.

Change

Previous filing in this sequence was filed on 24 Jun 2021.
Current net transaction value: +$33,331.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXDX transaction

Common Stock

Award

Transaction value: $33,331
Shares: +4,340
Change %: +3.9%
Price: $7.68
Shares after: 117,038
Date: 30 Sep 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. in connection with the closing of the third and final tranche of an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The third and final tranche of the offering closed on September 30, 2021.